Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

39.28
BATS BZX Real-Time Price
As of 1:54pm ET
 +0.61 / +1.58%
Today’s Change
29.39
Today|||52-Week Range
45.87
+2.96%
Year-to-Date
Pharma Stock Roundup: FDA Nod for NVO's Ozempic, Second Indication for Lilly's Taltz
Dec 08 / Zacks.com - Paid Partner Content
3 Drug/Biotech Stocks in Focus on World AIDS Day
Dec 01 / Zacks.com - Paid Partner Content
Staying Liquid
Dec 07 / TheStreet.com - Paid Partner Content
Cancer Space Update: Pfizer's Bavencio Fails in Phase III
Dec 01 / Zacks.com - Paid Partner Content
Pzena Investments Buys Mylan, Hewlett Packard, Wells Fargo
Dec 05 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Chang...
Dec 01 / Zacks.com - Paid Partner Content
Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest
Dec 04 / Zacks.com - Paid Partner Content
Glaxo Stock Down So Far This Year: Is a Reversal in Store?
Nov 30 / Zacks.com - Paid Partner Content
Will the Healthcare Landscape Change with the $69B CVS-Aetna Deal?
Dec 04 / Zacks.com - Paid Partner Content
5 Biotech and Pharma Stocks with FDA Catalysts this December
Nov 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.67
Today’s open38.40
Day’s range38.26 - 39.41
Volume220,361
Average volume (3 months)6,949,449
Market cap$20.7B
Dividend yield--
Data as of 1:54pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)-6.97%
Earnings growth (next 5 years)+3.46%
Revenue growth (last year)+17.44%
P/E ratio23.8
Price/Sales1.79
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+5.81+7.09%
PRGOPerrigo Company PLC+0.55+0.64%
JAZZJazz Pharmaceuticals...+1.23+0.89%
ALNYAlnylam Pharmaceutic...-3.14-2.40%
Data as of 1:53pm ET, 12/11/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)$1.41
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts